Kintara Therapeutics Inc Stock Ownership - Who owns Kintara Therapeutics?

Insider buying vs selling

Have Kintara Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when KTRA insiders and whales buy or sell their stock.

KTRA Shareholders

What type of owners hold Kintara Therapeutics Inc stock?
Dennis M. Brown234.54%3,929,265$14.46MInsider
William J. Garner144.76%2,425,207$8.92MInsider
Howard K. Fuguet74.61%1,250,000$4.60MInsider
Donald G. Bahouth62.23%1,042,500$3.84MInsider
Raymond L. Vollintine60.62%1,015,500$3.74MInsider
Robert E. Hoffman27.17%455,145$1.67MInsider
John K. Bell21.80%365,139$1.34MInsider
Anthony Scott Praill16.55%277,273$1.02MInsider
John Liatos11.74%196,750$724.04kInsider
Keith Murphy10.80%181,010$666.12kInsider

1 of 3

KTRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SNPX6.01%3.66%Net Selling

Kintara Therapeutics Stock Ownership FAQ

Who owns Kintara Therapeutics?

Kintara Therapeutics (NASDAQ: KTRA) is owned by 4.02% institutional shareholders, 673.08% Kintara Therapeutics insiders, and 0.00% retail investors. Dennis M. Brown is the largest individual Kintara Therapeutics shareholder, owning 3.93M shares representing 234.54% of the company. Dennis M. Brown's Kintara Therapeutics shares are currently valued at $14.46M.

If you're new to stock investing, here's how to buy Kintara Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.